You are here

Article Text

Article menu
Download PDFPDF
My neurological hobby horse
Treating by numbers
  1. Timothy J Counihan1,2
    1. 1Department of Neurology, Galway University Hospitals, Galway, Ireland
    2. 2School of Medicine, National University of Ireland Galway.
    1. Correspondence to Dr Timothy J Counihan, Department of Neurology, Galway University Hospitals, Galway, H91 YR71, Ireland; timothy.counihan{at}hse.ie

    http://dx.doi.org/10.1136/practneurol-2018-001939

    Statistics from Altmetric.com

      Request Permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

      Registrar: ‘Hello, am I speaking with the consultant neurologist on-call?’

      Consultant: ‘Regrettably! Yes that’s me. What is it?’

      R: ‘Hi this is Dr Richter, medical reg. on call. Sorry to disturb you so late, but we’ve got a FAST1 positive in A&E.’

      C: ‘A what?’

      R: ‘A FAST-positive patient.’

      C: ‘I assume that’s worse than a FAST-negative patient then. Go on.’

      R: ‘Well the NIHSS2 is 24 but her GCS3 4 is 12 currently. Before we got the CT, I was worried about a subarachnoid, because her Hunt & Hess5 was 4.’

      C: ‘Gosh.’

      R: ‘But thankfully the CT showed no bleed, but the ASPECTS6 was 6.’

      C: ‘Six, did you say? That doesn’t sound too bad. At least it’s not 10 or something.’

      R: ‘Actually 10 is a normal score. You really don’t want an ASPECTS lower than 6.’

      C: ‘I see. So what are you recommending to do?’

      R: ‘Well, time is brain, Professor, and I think it would be good to keep our door-to-needle stats …

      View Full Text

      Footnotes

      • Contributors The author is the sole contributor to the text. Mr Aongus Collins (collaborator) provided the figure.

      • Funding The author has not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

      • Competing interests None declared.

      • Patient consent Not required.

      • Provenance and peer review Not commissioned. Externally peer reviewed by Charles Warlow, Edinburgh, UK.

      • Collaborators Aongus Collins.

      Linked Articles

      • Editors’ commentary
        Highlights from this issue
        Philip E M Smith Geraint N Fuller
        Practical Neurology 2018; 18 347-347 Published Online First: 17 Sep 2018. doi: 10.1136/practneurol-2018-002077

      Other content recommended for you